Trial Profile

Digital Ischaemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-label Multicenter Extension Study

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Treprostinil (Primary)
Indications Systemic scleroderma
Focus Therapeutic Use
Acronyms DISTOL-EXT
Sponsors United Therapeutics Corporation

Most Recent Events

15 Jun 2016 Results of a retrospective study from DISTOL-1 and DISTOL-EXT assessing digital ulcers burden after withdrawal from oral treprostinil (n = 51) published in The Journal of Rheumatology
25 Jun 2014 New trial record
31 Oct 2012

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com